Unidade Local de Saúde de Braga

Braga 4710-243

1 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Primary Progressive, Non-Small Cell Lung Cancer (NSCLC)

Studies at this site

• A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis — Running, not enrolling